| Nov 18 |
Steris Q2: Anticipating HSD Growth In AST, Upgrade To 'Buy'
|
| Nov 11 |
Why Steris (STE) International Revenue Trends Deserve Your Attention
|
| Nov 8 |
Steris PLC (STE) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid Margin Pressures
|
| Nov 8 |
Q2 2025 STERIS plc Earnings Call
|
| Nov 7 |
STERIS plc (STE) Q2 2025 Earnings Call Transcript
|
| Nov 7 |
STERIS Shares Slide 4% Despite Strong EPS Beat and Growth in Key Segments
|
| Nov 7 |
STE Q2 Earnings Beat Estimates, Margins Dip, Stock Gains in Aftermarket
|
| Nov 7 |
Compared to Estimates, Steris (STE) Q2 Earnings: A Look at Key Metrics
|
| Nov 6 |
Steris (STE) Surpasses Q2 Earnings Estimates
|
| Nov 6 |
Steris Non-GAAP EPS of $2.14 beats by $0.01, revenue of $1.3B
|
